The Fierce Pharma website provides a rolling coverage of JPM24- link below. Every opening day of the conference EY's Firepower report comes out assessing the capacity of the industry's top 25 companies to execute M & A deals based on the strength of their balance sheet. See the very bottom of the page on the below link.
EY tabulated the available firepower of the companies at $1.37 trillion entering 2024, which is the second-highest figure in the 10 years of the analysis. Another factor that bodes well for M&A in 2024 is the sudden surge in high-dollar deals at the end of 2023. Several other elements are in play—including patent expirations, government regulations and the recent failure of several late-stage assets—which signal urgency by large pharma companies to make deals for late-stage and commercial assets, EY analysts say. Story
https://www.fiercepharma.com/pharma/jpm24-day-1-bms-novartis-amgen-and-more
The Fierce Pharma website provides a rolling coverage of JPM24-...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.06 |
Change
-0.140(0.73%) |
Mkt cap ! $2.433B | |||
| Open | High | Low | Value | Volume |
| $18.76 | $19.35 | $18.71 | $7.893M | 414.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 5037 | $19.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.16 | 881 | 1 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.11 |
Change
-0.140 ( 0.78 %) |
||||
| Open | High | Low | Volume | ||
| $18.80 | $19.34 | $18.73 | 92009 | ||
| Last updated 15.59pm 01/05/2024 ? | |||||
| NEU (ASX) Chart |